Kevin John Conway - 10 Jan 2025 Form 3 Insider Report for Generation Bio Co. (GBIO)

Role
Chief Financial Officer
Signature
/s/ Shawna-Gay White, Attorney-in-Fact
Issuer symbol
GBIO
Transactions as of
10 Jan 2025
Net transactions value
$0
Form type
3
Filing time
14 Jan 2025, 16:12:17 UTC
Next filing
17 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding GBIO Common Stock 17,062 10 Jan 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding GBIO Stock Option (right to buy) 10 Jan 2025 Common Stock 11,927 $6.36 Direct F1
holding GBIO Stock Option (right to buy) 10 Jan 2025 Common Stock 1,132 $5.16 Direct F2
holding GBIO Stock Option (right to buy) 10 Jan 2025 Common Stock 1,700 $5.16 Direct F3
holding GBIO Stock Option (right to buy) 10 Jan 2025 Common Stock 10,621 $19.00 Direct F4
holding GBIO Stock Option (right to buy) 10 Jan 2025 Common Stock 6,210 $30.25 Direct F5
holding GBIO Stock Option (right to buy) 10 Jan 2025 Common Stock 14,000 $31.69 Direct F6
holding GBIO Stock Option (right to buy) 10 Jan 2025 Common Stock 25,856 $6.49 Direct F7
holding GBIO Stock Option (right to buy) 10 Jan 2025 Common Stock 28,000 $8.18 Direct F8
holding GBIO Stock Option (right to buy) 10 Jan 2025 Common Stock 18,781 $4.70 Direct F9
holding GBIO Stock Option (right to buy) 10 Jan 2025 Common Stock 5,500 $5.06 Direct F10
holding GBIO Stock Option (right to buy) 10 Jan 2025 Common Stock 17,634 $1.39 Direct F11
holding GBIO Stock Option (right to buy) 10 Jan 2025 Common Stock 59,400 $1.86 Direct F12
holding GBIO Stock Option (right to buy) 10 Jan 2025 Common Stock 2,000 $4.29 Direct F13
holding GBIO Stock Option (right to buy) 10 Jan 2025 Common Stock 2,500 $3.16 Direct F14
holding GBIO Restricted Stock Units 10 Jan 2025 Common Stock 5,281 Direct F15, F16
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option to purchase 15,852 shares was granted on August 12, 2019. The shares underlying the option vest over four years, with 25% of the shares vested on July 22, 2020 and the remaining shares vesting in equal quarterly installments thereafter.
F2 The option to purchase 2,264 shares was granted on March 5, 2020. The shares underlying the option vested over two years, with 25% of the shares vested on August 24, 2020 and the remaining shares vesting in equal quarterly installments thereafter.
F3 The option to purchase 2,264 shares was granted on March 5, 2020. The shares underlying the option vested over four years, with 25% of the shares vested on March 5, 2021 and the remaining shares vesting in equal quarterly installments thereafter.
F4 The option to purchase 10,621 shares was granted on June 11, 2020. The shares underlying the option vested over four years, with 25% of the shares vested on April 1, 2021 and the remaining shares vesting in equal quarterly installments thereafter.
F5 The option to purchase 6,210 shares was granted on January 22, 2021. The shares underlying the option vested over four years, with 25% of the shares vested on January 22, 2022 and the remaining shares vesting in equal quarterly installments thereafter.
F6 The option to purchase 14,000 shares was granted on June 1, 2021. The shares underlying the option vested over four years, with 25% of the shares vested on May 1, 2022 and the remaining shares vesting in equal quarterly installments thereafter.
F7 The option to purchase 25,856 shares was granted on January 21, 2022. The shares underlying the option vested over four years, with 25% of the shares vested on January 21, 2023 and the remaining shares vesting in equal quarterly installments thereafter.
F8 The option to purchase 28,000 shares was granted on April 1, 2022. The shares underlying the option vested over four years, with 25% of the shares vested on March 1, 2023 and the remaining shares vesting in equal quarterly installments thereafter.
F9 The option to purchase 18,781 shares was granted on January 20, 2023. The shares underlying the option vested over four years, with 25% of the shares vested on January 20, 2024 and the remaining shares vesting in equal quarterly installments thereafter.
F10 The option to purchase 5,500 shares was granted on September 1, 2023. The shares underlying the option vested over two years, with 25% of the shares vested on March 1, 2024 and the remaining shares vesting in equal quarterly installments thereafter.
F11 The option to purchase 28,215 shares was granted on December 1, 2023. The shares underlying the option vested over two years, with 25% of the shares vested on June 1, 2024 and the remaining shares vesting in equal quarterly installments thereafter.
F12 The option to purchase 59,400 shares was granted on January 2, 2024. The shares underlying the option vested over four years, with 25% of the shares vesting on January 2, 2025 and the remaining shares vesting in equal quarterly installments thereafter.
F13 The option to purchase 2,000 shares was granted on April 1, 2024. The shares underlying the option vested over two years, with 25% of the shares vested on October 1, 2024 and the remaining shares vesting in equal quarterly installments thereafter.
F14 The option to purchase 2,500 shares was granted on August 1, 2024. The shares underlying the option vested over two years, with 25% of the shares vesting on February 1, 2025 and the remaining shares vesting in equal quarterly installments thereafter.
F15 The grant of 9,390 restricted stock units was made on January 20, 2023. The shares underlying the restricted stock units vest over four years, with 25% of the shares vested on January 15, 2024 and the remaining shares vesting in equal quarterly installments thereafter.
F16 Each restricted stock unit represents the right to receive one share of the company's common stock.